Harm reduction: evidence, impacts and challenges
The EMCDDA’s 10th scientific monograph, entitled Harm reduction: evidence, impacts and challenges provides a comprehensive overview of the harm reduction field. Part I of the monograph looks back at the emergence of harm reduction approaches and their diffusion, and explores the concept from different perspectives, including international organisations, academic researchers and drug users. Part II is dedicated to current evidence and impacts of harm reduction and illustrates how the concept has broadened to cover a wide range of behaviours and harms. Part III addresses the current challenges and innovations in the field. The core audience of the monograph comprises policymakers, healthcare professionals working with drug users, as well as the wider interested public.
Table of contents
Please find below a detailed table of contents with downloadable PDFs per chapter.
Part I: Background
Part II: Evidence and impacts
- Chapter 5: Harm reduction among injecting drug users — evidence of effectiveness Jo Kimber, Norah Palmateer, Sharon Hutchinson, Matthew Hickman, David Goldberg and Tim Rhodes
- Chapter 6: The effect of epidemiological setting on the impact of harm reduction targeting injecting drug users Peter Vickerman and Matthew Hickman
- Chapter 7: The fast and furious — cocaine, amphetamines and harm reduction Jean-Paul Grund, Philip Coffin, Marie Jauffret-Roustide, Minke Dijkstra, Dick de Bruin and Peter Blanken
- Chapter 8: Harm reduction policies for cannabis Wayne Hall and Benedikt Fischer
- Chapter 9: Harm reduction policies for tobacco Coral Gartner, Wayne Hall and Ann McNeill
- Chapter 10: Alcohol harm reduction in Europe Rachel Herring, Betsy Thom, Franca Beccaria, Torsten Kolind and Jacek Moskalewicz
Part III: Challenges and innovations
Downloads of individual chapters